CVS Health (NYSE: CVS) reported Q4 EPS of $1.19, $0.19 better than the analyst estimate of $1.00. Revenue for the quarter came in at $97.7 billion versus the consensus estimate of $96.97 billion.

GUIDANCE:

CVS Health sees FY2025 EPS of $5.75-$6.00, versus the consensus of $5.97.

For earnings history and earnings-related data on CVS Health (CVS) click here.